Inflammatory Bowel Disease (IBD) centers dealing with patients having chronic conditions had to quickly adapt to use home monitoring tools during the COVID-19 pandemic, including IBDoc®, as a mean to safely test fecal calprotectin.
- info@buhlmannlabs.ch
- +41 61 487 12 12
News
South Korea’s biotechnology firm Seegene (KQ096530) said Monday it developed the world’s first COVID-19 diagnostic variant test, capable of screening COVID-19 and identifying multiple mutant variations in a single reaction.
BÜHLMANN is proud to release the first Polyethylene glycol (PEG) Allergens for the Flow CAST® basophil activation assay.
Read more about the successful introduction of the new fecal pancreatic elastase BÜHLMANN fPELA® turbo assay at the Medical Laboratory Center Dr. Risch in Switzerland.
Social Links